{"gene":"ARFGEF1","run_date":"2026-06-09T22:02:44","timeline":{"discoveries":[{"year":1999,"finding":"Human p200 ARF-GEP1 (ARFGEF1) is a Golgi-localized guanine nucleotide exchange factor whose Sec7 domain catalyzes GTP loading onto class I ARFs; brefeldin A acts as an uncompetitive inhibitor targeting the p200-ARF complex (Ki ~7 µM) rather than competing with ARF for p200 binding. Golgi localization signal maps to the N-terminal third of the protein.","method":"GTPγS loading assay (in vitro GEF activity), kinetic inhibition analysis, tagged-protein cellular localization by immunofluorescence, truncation mapping","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro enzymatic reconstitution with kinetic analysis and truncation mapping, replicated across multiple constructs","pmids":["10393931"],"is_preprint":false},{"year":2003,"finding":"The N-terminal region (aa 1–331) of BIG1 interacts with FK506-binding protein 13 (FKBP13); this association was confirmed by co-immunoprecipitation of endogenous BIG1 and FKBP13 from Jurkat T cells. FK506 treatment increased membrane binding of BIG1, BIG2, and ARF to Golgi and other membranes.","method":"Yeast two-hybrid screen, co-immunoprecipitation of endogenous proteins, in vitro membrane-binding assay with GTPγS","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — yeast two-hybrid plus reciprocal co-IP of endogenous proteins, single lab","pmids":["12606707"],"is_preprint":false},{"year":2004,"finding":"BIG1 localizes to nuclei (nuclear envelope/nucleoli) in serum-starved HepG2 cells independently of BIG2; nuclear BIG1 co-immunoprecipitates with nucleoporin p62 and nucleolin, but ARF is not detected in nuclear BIG1 immunoprecipitates, indicating independent nuclear functions distinct from Golgi ARF activation.","method":"Confocal immunofluorescence microscopy, subcellular fractionation, Western blot, co-immunoprecipitation from purified nuclei","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (microscopy, fractionation, co-IP) in single lab","pmids":["14973189"],"is_preprint":false},{"year":2005,"finding":"BIG1 directly binds to the zinc finger/GAP domain of myosin IXb and inhibits myosin IXb RhoA-GAP activity (IC50 ~0.06 µM) by competing with RhoA for the same binding region on myosin IXb.","method":"Yeast two-hybrid, co-immunoprecipitation of endogenous proteins, in vitro direct binding with purified proteins, GAP activity assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with purified proteins plus enzymatic assay and endogenous co-IP; multiple orthogonal methods in one study","pmids":["15644318"],"is_preprint":false},{"year":2006,"finding":"PKA-catalyzed phosphorylation of BIG1 at Ser-883 is required for cAMP-induced nuclear accumulation of BIG1; a functional nuclear localization signal (712KPK714) is also necessary. Microtubule integrity (nocodazole-sensitive) is required for translocation. BIG2 is not similarly regulated.","method":"Site-directed mutagenesis (S883A, S883D, NLS mutant), immunofluorescence microscopy, PKA inhibitor (H-89, PKI) treatments, nocodazole treatment","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Moderate — mutagenesis of phosphorylation site and NLS with cellular functional readout, multiple orthogonal approaches in single rigorous study","pmids":["16467138"],"is_preprint":false},{"year":2007,"finding":"PKA phosphorylates BIG1, significantly decreasing its GEF activity toward ARFs; protein phosphatase 1γ (but not PP1α, PP1β, or PP2A) reverses this phosphorylation and restores GEP activity. Endogenous PP1γ co-immunoprecipitates with BIG1 from microsomal fractions. Elevated cAMP induces PKA-catalyzed phosphorylation and nuclear accumulation of BIG1 but not BIG2.","method":"In vitro kinase assay with recombinant PKA, in vitro phosphatase assay with recombinant phosphatases, GEP activity assay from immunoprecipitated BIG1, co-immunoprecipitation, okadaic acid treatment","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro enzymatic assays (kinase, phosphatase, GEF) combined with endogenous co-IP; multiple orthogonal methods in one rigorous study","pmids":["17360629"],"is_preprint":false},{"year":2007,"finding":"BIG1 is required for correct N-glycosylation of integrin β1 in the Golgi; BIG1 siRNA (but not BIG2 siRNA) causes aberrant electrophoretic mobility of β1, decreased active RhoA-GTP, impaired cell spreading, adhesion, and migration. Overexpression of HA-BIG1 restores RhoA-GTP levels.","method":"siRNA knockdown, PNGase F and EndoH glycosidase digestion, Western blot, electron microscopy (Golgi morphology), immunofluorescence, RhoA pull-down activity assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (glycosidase treatment, EM, activity assay, rescue by OE) in single lab","pmids":["17227842"],"is_preprint":false},{"year":2007,"finding":"BIG1 and BIG2 form homodimers through interactions between their conserved DCB domains; within each homodimer the DCB domain also interacts with the HUS domain via the HUS box. Both DCB and HUS domains are necessary for GBF1 dimerization in mammalian cells; the DCB domain is essential for yeast viability.","method":"Yeast two-hybrid assay, biochemical in vitro interaction assays, mammalian cell dimerization assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — yeast two-hybrid plus biochemical assays plus cellular assay; single lab with orthogonal methods","pmids":["17640864"],"is_preprint":false},{"year":2008,"finding":"BIG1 in nuclei of HepG2 cells associates with nucleolin, U3 snoRNA, and fibrillarin, dependent on nucleic acids (RNase A/DNase-sensitive); BIG1 and nucleolin also associate with nucleoporin p62 at the nuclear envelope, suggesting BIG1 participates in dynamic nucleolar complexes.","method":"Co-immunoprecipitation from purified nuclei, RNase/DNase sensitivity experiments, 32P RNA labeling, U3 snoRNA-specific hybridization","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP with nucleic acid dependency tested by enzymatic digestion, RNA identity confirmed by hybridization; single lab","pmids":["18292223"],"is_preprint":false},{"year":2008,"finding":"BIG1 and BIG2 play redundant roles in membrane trafficking between the TGN and endosomes, including retrograde transport of furin from late endosomes to the TGN and maintenance of localization of TGN/recycling endosome proteins; this overlaps functionally with AP-1 clathrin adaptor activity.","method":"siRNA double knockdown (BIG1 and BIG2), immunofluorescence microscopy, protein localization assays, epistasis with AP-1 depletion","journal":"Molecular biology of the cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis (double KD) with specific trafficking readout; single lab","pmids":["18417613"],"is_preprint":false},{"year":2009,"finding":"PDE3A interacts with BIG1 and BIG2 as part of AKAP complexes; depletion or inhibition of PDE3A disperses BIG1/BIG2 from the perinuclear Golgi and decreases membrane-associated ARF1-GTP, suggesting PDE3A limits local cAMP to prevent PKA-mediated inhibition of BIG1/BIG2 GEF activity.","method":"siRNA depletion of PDE3A, cilostamide pharmacological inhibition, confocal immunofluorescence, ARF1-GTP pull-down assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional readout (ARF1-GTP levels, localization) with pharmacological and genetic perturbations; single lab","pmids":["19332778"],"is_preprint":false},{"year":2010,"finding":"BIG1 (but not BIG2) depletion causes fragmentation of the Golgi apparatus into mini-stacks that remain polarized and functional for cargo export, demonstrating a non-redundant role for BIG1 in maintaining normal Golgi morphology.","method":"siRNA knockdown, fixed and live-cell fluorescence imaging, Golgi morphology analysis","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct comparative siRNA with cellular morphology readout; single lab","pmids":["20360857"],"is_preprint":false},{"year":2012,"finding":"The Arf-like GTPase Arl1 directly binds the N-terminal region of BIG1/BIG2 (via their Drosophila ortholog Sec71) and is necessary for Golgi recruitment of BIG1 and BIG2 (but not GBF1) to the trans-Golgi in mammalian cells.","method":"Liposome-based affinity purification of Arl1 effectors, Drosophila Sec71 binding assay, mammalian Arl1 knockdown with BIG1/BIG2 localization readout","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro affinity purification (direct binding) plus cellular knockdown with localization readout; orthogonal methods across species","pmids":["22291037"],"is_preprint":false},{"year":2012,"finding":"BIG1 associates with ABCA1 in vesicle preparations from rat liver; BIG1 depletion reduces surface ABCA1, inhibits its internalization and recycling, and decreases cholesterol efflux by ~60%. These effects depend on BIG1 GEF activity and ARF1 activation.","method":"Vesicle immunoprecipitation, siRNA knockdown, surface biotinylation/glutathione cleavage assay, cholesterol efflux assay, BIG1 overexpression rescue","journal":"Arteriosclerosis, thrombosis, and vascular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (vesicle co-IP, surface biotinylation, GEF-dependent rescue); single lab","pmids":["23220274"],"is_preprint":false},{"year":2013,"finding":"GBF1-activated ARF4 and ARF5 (but not ARF3) facilitate recruitment of BIG1 and BIG2 to the TGN, defining a functional GEF cascade where GBF1 at the TGN acts upstream of BIG1/BIG2 recruitment. GBF1 localizes ultrastructurally to pre-Golgi, Golgi, and TGN.","method":"Dominant-negative and activated ARF mutants, siRNA depletion of GBF1, immunofluorescence and immunoelectron microscopy for BIG1/BIG2 localization","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis using ARF mutants and GEF depletion with localization readout; single lab","pmids":["23386609"],"is_preprint":false},{"year":2013,"finding":"BIG1 and BIG2 form complexes with nonmuscle myosin IIA independently of their GEF catalytic activity (C-terminal sequences suffice for interaction); selective depletion of BIG1 or BIG2 enhances phosphorylation of myosin regulatory light chain (T18/S19) and F-actin content, impairing cell migration. BIG1/BIG2 scaffold myosin phosphatase complexes (including myosin IIA, PP1δ, and MYPT1) to regulate myosin IIA activity.","method":"Reciprocal co-immunoprecipitation of endogenous proteins, siRNA depletion, C-terminal rescue constructs (GEF-inactive), phospho-myosin light chain Western blot, F-actin quantification, Transwell migration assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal endogenous co-IP, GEF-activity-independent rescue, multiple cellular phenotypes (phosphorylation, actin, migration); single lab but multiple orthogonal methods and strong controls","pmids":["23918382"],"is_preprint":false},{"year":2013,"finding":"BIG1 directly binds GABAA receptor subunits and is required for their trafficking to the neuronal cell surface via its GEF activity; BIG1 depletion or dominant-negative BIG1-E793K expression reduces surface GABAAR and suppresses GABA-gated chloride influx.","method":"Co-immunoprecipitation (BIG1–GABAAR), siRNA knockdown, dominant-negative overexpression, surface GABAAR quantification, electrophysiology (Cl− influx assay)","journal":"Molecular neurobiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP plus functional assay plus dominant-negative; single lab","pmids":["24198228"],"is_preprint":false},{"year":2013,"finding":"BIG1 GEF activity regulates neurite development via PI3K-AKT signaling (GEF-activity-dependent) and ERK signaling (partially GEF-activity-independent); BIG1 colocalizes with synaptophysin and its expression increases during rat brain development.","method":"siRNA knockdown, brefeldin A inhibition, dominant-negative BIG1 overexpression, wild-type BIG1 overexpression, phospho-Western blot for PI3K/AKT/ERK, neurite length measurement, immunostaining","journal":"Neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple genetic/pharmacological perturbations with pathway-specific readouts; single lab","pmids":["24090963"],"is_preprint":false},{"year":2016,"finding":"BIG1 directly interacts with β-catenin via its N-terminal sequence; depletion of BIG1 and/or BIG2 or GEF-inactive mutant expression causes β-catenin accumulation at perinuclear Golgi and reduces PKA-phosphorylated β-catenin (S675). BIG2 AKAP-C sequence is required for PKA-mediated S675 phosphorylation and β-catenin transcription coactivator function. Effects require phospholipase D activity and vesicular trafficking.","method":"Yeast two-hybrid, in vitro synthesized protein binding, co-immunoprecipitation, siRNA depletion, GEF-inactive mutant, immunofluorescence, phospho-Western blot, transcriptional reporter assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — yeast two-hybrid plus in vitro binding plus co-IP plus functional readouts; single lab","pmids":["27162341"],"is_preprint":false},{"year":2016,"finding":"BIG1 is required for recruitment of TRAF2 to TNFR1 signaling complex (complex I) and to the death-inducing signaling complex (complex II) after TNF-α stimulation; BIG1 knockdown attenuates TNF-α-induced TRAF2 ubiquitination and JNK activation, and increases apoptosis sensitivity.","method":"siRNA knockdown, TNF-α stimulation, TNFR1 complex immunoprecipitation, TRAF2 ubiquitination assay, JNK activation Western blot, apoptosis assay","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — complex immunoprecipitation with ubiquitination and kinase activity readouts; single lab","pmids":["27834853"],"is_preprint":false},{"year":2017,"finding":"BIG1 loss in mice causes apoptosis of Tbr1+/Ctip2+ deep-layer neurons in a spatial-temporal pattern, impairs neuronal polarization in vitro, renders neurons hypersensitive to glutamate-induced apoptosis, and causes ectopic corticothalamic axon projections and failure of thalamocortical axons to cross the DTB.","method":"BIG1 knockout mouse (full KO), immunohistochemistry, pulse-chase migration assay, primary neuron culture, in vitro polarization assay, low-dose glutamate challenge","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO with multiple cellular and in vivo phenotype readouts; single lab","pmids":["28414797"],"is_preprint":false},{"year":2018,"finding":"BIG1/Arfgef1 and its effector Arf1 are required for initiation of myelination by Schwann cells; Schwann cell-specific BIG1 conditional KO mice show reduced myelin thickness and decreased myelin protein zero (P0) in the myelin membrane. BIG1 KO specifically reduces Arf1 association with AP-1 clathrin adaptor subunits (but not GGA1 or COPI), indicating AP-1-dependent trafficking is the relevant effector pathway.","method":"Schwann cell-specific conditional KO mouse (BIG1 and Arf1), electron microscopy (myelin thickness), immunofluorescence (P0 localization), co-immunoprecipitation (Arf1 with AP-1, GGA1, COPI subunits), Western blot","journal":"Science advances","confidence":"High","confidence_rationale":"Tier 2 / Strong — cell-type-specific conditional KO with ultrastructural readout, mechanistic dissection of effector pathway by co-IP; replicated with parallel Arf1 conditional KO","pmids":["29740613"],"is_preprint":false},{"year":2019,"finding":"Arfgef1 haploinsufficiency in mice alters neuronal endosome composition (altered ratio of Arf6+:Rab11+:TrfR+ recycling endosomes) and reduces dendritic surface and synaptic GABAA receptor levels (with increased lysosomal targeting), resulting in decreased seizure threshold but no spontaneous seizures.","method":"Heterozygous frameshift mouse model, primary hippocampal neuron culture, surface/synaptic GABAAR immunostaining, endosome marker quantification, pentylenetetrazol seizure threshold assay","journal":"Neurobiology of disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mouse haploinsufficiency model with mechanistic trafficking readouts; single lab","pmids":["31678406"],"is_preprint":false},{"year":2020,"finding":"BIG1 promotes macrophage pro-inflammatory responses in sepsis via ARF3 activation, which stimulates PIP5K-mediated PI(4,5)P2 synthesis and TIRAP recruitment to the plasma membrane, thereby activating TLR4-MyD88 signaling. Myeloid-specific BIG1 cKO reduces sepsis mortality and organ damage.","method":"Myeloid-specific BIG1 conditional KO mouse (LPS and CLP models), bone marrow-derived macrophage cultures, ARF3 activation assay, PI(4,5)P2 measurement, TIRAP membrane recruitment assay, TLR4/MyD88/NF-κB pathway Western blot, cytokine ELISA","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO mouse with mechanistic pathway dissection (ARF3→PIP5K→PI(4,5)P2→TIRAP); multiple methods, single lab","pmids":["32415087"],"is_preprint":false},{"year":2022,"finding":"14-3-3ζ interacts with both GABAA receptor β subunit and BIG1 in vitro and in vivo (hippocampal neurons); overexpression of 14-3-3ζ increases BIG1 surface expression and BIG1–GABAAR interaction, while 14-3-3ζ depletion reduces surface expression of both BIG1 and GABAAR and suppresses GABA-gated chloride influx.","method":"Co-immunoprecipitation (in vitro and in vivo), siRNA depletion, overexpression, immunofluorescence, surface expression quantification, Cl− influx assay","journal":"Molecular neurobiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro and in vivo co-IP plus functional ion channel readout; single lab","pmids":["36562883"],"is_preprint":false},{"year":2022,"finding":"KLF4 transcriptionally activates BIG1 (ARFGEF1) by binding its promoter (confirmed by ChIP-qPCR and dual-luciferase reporter assay); BIG1 mediates LPS-induced microglial neuroinflammation and migration via the PI3K/Akt/NF-κB pathway.","method":"ChIP-qPCR, dual-luciferase reporter assay, siRNA knockdown, PI3K agonist (740Y-P) rescue, RT-qPCR, ELISA, Transwell migration assay, Western blot","journal":"Neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and luciferase assay confirm promoter binding; pathway placement by pharmacological rescue; single lab","pmids":["35090882"],"is_preprint":false}],"current_model":"ARFGEF1/BIG1 is a ~200 kDa Golgi-localized guanine nucleotide exchange factor that activates class I ARFs (ARF1, ARF3) via its Sec7 domain (inhibited uncompetitively by brefeldin A); it is recruited to the trans-Golgi by Arl1 (downstream of GBF1-activated ARFs) and regulates AP-1-dependent vesicular trafficking between the TGN and endosomes, Golgi morphology maintenance, integrin β1 glycosylation, ABCA1 and GABAA receptor surface trafficking, and myelination initiation in Schwann cells; beyond its GEF activity, BIG1 scaffolds myosin phosphatase complexes (with myosin IIA, PP1δ, MYPT1) to control actomyosin dynamics and cell migration, interacts with myosin IXb to inhibit its RhoA-GAP activity, associates with TRAF2 to support TNFR1 signaling, binds β-catenin and FKBP13, and undergoes PKA-catalyzed phosphorylation at Ser-883 (reversed by PP1γ) that both reduces its GEF activity and drives nuclear translocation via an NLS and microtubules, where it associates with nucleolin, U3 snoRNA, and fibrillarin in nucleolar complexes; in macrophages, BIG1 promotes pro-inflammatory TLR4 signaling through ARF3-dependent PI(4,5)P2 synthesis and TIRAP membrane recruitment, and haploinsufficiency in humans causes autosomal dominant neurodevelopmental disorder with epilepsy attributed to impaired vesicle trafficking affecting neuronal GABAA receptor surface expression."},"narrative":{"mechanistic_narrative":"ARFGEF1/BIG1 is a Golgi-localized guanine nucleotide exchange factor that activates class I ARFs via its Sec7 domain to drive vesicular trafficking, with brefeldin A acting as an uncompetitive inhibitor of the BIG1–ARF complex [PMID:10393931]. It is recruited to the trans-Golgi by the Arf-like GTPase Arl1 binding its N-terminal region [PMID:22291037], downstream of a GEF cascade in which GBF1-activated ARF4/ARF5 promote BIG1/BIG2 TGN recruitment [PMID:23386609], where BIG1 acts redundantly with BIG2 in AP-1-dependent transport between the TGN and endosomes [PMID:18417613] while non-redundantly maintaining Golgi morphology [PMID:20360857]. Through its GEF activity BIG1 controls surface trafficking of multiple cargoes, including integrin β1 glycosylation and RhoA activation [PMID:17227842], ABCA1 recycling and cholesterol efflux [PMID:23220274], and neuronal GABAA receptor surface expression [PMID:24198228]. Its catalytic activity is subject to a cAMP/PKA switch: PKA phosphorylates Ser-883 to reduce GEF activity and is reversed by PP1γ [PMID:17360629], while PDE3A-containing AKAP complexes limit local cAMP to sustain ARF1 activation [PMID:19332778]; the same phosphorylation, together with an NLS and intact microtubules, drives nuclear/nucleolar translocation where BIG1 associates with nucleolin, U3 snoRNA, and fibrillarin [PMID:16467138, PMID:18292223]. Beyond catalysis, BIG1 scaffolds nonmuscle myosin IIA phosphatase complexes (with PP1δ and MYPT1) to regulate actomyosin dynamics and cell migration [PMID:23918382] and binds myosin IXb to inhibit its RhoA-GAP activity [PMID:15644318]. In immune and neural contexts it promotes pro-inflammatory TLR4 signaling via ARF3-dependent PI(4,5)P2 synthesis and TIRAP recruitment [PMID:32415087], supports TNFR1 complex assembly through TRAF2 recruitment [PMID:27834853], and is required for Schwann cell myelination through ARF1/AP-1-dependent trafficking [PMID:29740613]. Loss-of-function studies establish that BIG1 is essential for cortical neuron survival and axon guidance [PMID:28414797], and haploinsufficiency reduces seizure threshold via impaired GABAA receptor trafficking [PMID:31678406].","teleology":[{"year":1999,"claim":"Established the core biochemical identity of BIG1 as a brefeldin-A-sensitive ARF guanine nucleotide exchange factor, answering what enzymatic activity the protein carries and where it acts.","evidence":"In vitro GTPγS loading assays with kinetic inhibition analysis and truncation mapping of the Golgi localization signal","pmids":["10393931"],"confidence":"High","gaps":["Did not identify upstream recruiters or downstream trafficking cargoes","ARF isoform selectivity in vivo not resolved"]},{"year":2003,"claim":"Identified the first physical interaction partner (FKBP13) and linked immunophilin signaling to BIG1 membrane association.","evidence":"Yeast two-hybrid and reciprocal co-IP of endogenous proteins from Jurkat cells with GTPγS membrane-binding assay","pmids":["12606707"],"confidence":"Medium","gaps":["Functional consequence of the BIG1–FKBP13 interaction unresolved","Single lab, no in vivo phenotype"]},{"year":2005,"claim":"Revealed a GEF-independent function by showing BIG1 directly inhibits myosin IXb RhoA-GAP activity, connecting BIG1 to Rho-GTPase regulation.","evidence":"Yeast two-hybrid, direct binding of purified proteins, GAP activity assay, endogenous co-IP","pmids":["15644318"],"confidence":"High","gaps":["Cellular RhoA-pathway consequence not demonstrated in this study","Structural basis of competition with RhoA not defined"]},{"year":2004,"claim":"Demonstrated that BIG1 has a nuclear/nucleolar pool distinct from its Golgi ARF-activation role, since nuclear BIG1 lacked associated ARF but bound nucleolin and nucleoporin p62.","evidence":"Confocal microscopy, subcellular fractionation, and co-IP from purified nuclei of serum-starved HepG2 cells","pmids":["14973189"],"confidence":"Medium","gaps":["Molecular function of nuclear BIG1 not established","Trigger for nuclear pool size not quantified"]},{"year":2006,"claim":"Defined the mechanism of nuclear translocation, showing PKA phosphorylation at Ser-883 plus a functional NLS and microtubule integrity are required.","evidence":"Site-directed mutagenesis of S883 and NLS, immunofluorescence, PKA inhibitors, and nocodazole treatment","pmids":["16467138"],"confidence":"High","gaps":["Nuclear activity of translocated BIG1 not assayed","Identity of nuclear import machinery beyond NLS not defined"]},{"year":2007,"claim":"Connected the PKA phosphorylation switch to catalytic regulation, showing phosphorylation lowers GEF activity and PP1γ specifically reverses it.","evidence":"In vitro kinase, phosphatase, and GEF assays plus endogenous PP1γ co-IP from microsomes","pmids":["17360629"],"confidence":"High","gaps":["Whether GEF inhibition and nuclear translocation are coupled or separable not resolved","Spatial coordination of the kinase/phosphatase not mapped"]},{"year":2007,"claim":"Linked BIG1 GEF function to a specific cargo pathway, showing it is required for integrin β1 glycosylation, RhoA activation, and cell migration, non-redundantly with BIG2.","evidence":"siRNA knockdown, glycosidase digestion, EM, RhoA pull-down, and overexpression rescue","pmids":["17227842"],"confidence":"Medium","gaps":["Direct enzymatic step controlled by BIG1 in glycosylation not defined","Link between Golgi trafficking and RhoA activation mechanistically incomplete"]},{"year":2008,"claim":"Refined the nuclear function by placing BIG1 in nucleic-acid-dependent nucleolar complexes with nucleolin, U3 snoRNA, and fibrillarin.","evidence":"Co-IP from purified nuclei with RNase/DNase sensitivity and U3 snoRNA hybridization","pmids":["18292223"],"confidence":"Medium","gaps":["Role in rRNA processing or ribosome biogenesis not tested","Whether GEF activity is involved in the nucleolus unknown"]},{"year":2007,"claim":"Established the structural basis for BIG-protein dimerization through DCB–DCB and DCB–HUS interactions, defining how the GEF self-associates.","evidence":"Yeast two-hybrid, in vitro biochemical interaction, and mammalian dimerization assays","pmids":["17640864"],"confidence":"Medium","gaps":["Functional consequence of dimerization for GEF activity not quantified","Hetero- vs homodimer preference in vivo unresolved"]},{"year":2008,"claim":"Defined BIG1/BIG2 as redundant regulators of TGN–endosome trafficking acting in the AP-1 clathrin pathway, including furin retrograde transport.","evidence":"Double siRNA knockdown with trafficking readouts and AP-1 epistasis","pmids":["18417613"],"confidence":"Medium","gaps":["Direct mechanistic link between ARF activation and AP-1 recruitment not shown here","Cargo specificity beyond furin not delineated"]},{"year":2009,"claim":"Showed that PDE3A-containing AKAP complexes sustain BIG1/BIG2 GEF activity by limiting local cAMP, integrating the PKA switch with localized signaling.","evidence":"siRNA and pharmacological PDE3A inhibition, confocal microscopy, and ARF1-GTP pull-down","pmids":["19332778"],"confidence":"Medium","gaps":["Direct scaffolding architecture of the AKAP complex not resolved","In vivo relevance not tested"]},{"year":2010,"claim":"Distinguished a non-redundant role for BIG1 in maintaining Golgi morphology, separable from cargo export function.","evidence":"Comparative siRNA with fixed and live-cell Golgi imaging","pmids":["20360857"],"confidence":"Medium","gaps":["Mechanism by which BIG1 maintains ribbon integrity unknown","Effector linking GEF activity to morphology not identified"]},{"year":2012,"claim":"Identified Arl1 as the direct recruiter of BIG1 to the trans-Golgi, answering how the GEF is targeted to membranes.","evidence":"Liposome affinity purification, Drosophila Sec71 binding, and Arl1 knockdown with localization readout across species","pmids":["22291037"],"confidence":"High","gaps":["How Arl1 binding relates to PKA-regulated cytosolic/nuclear pools unresolved","Stoichiometry of recruitment not defined"]},{"year":2012,"claim":"Extended the GEF-dependent cargo repertoire to ABCA1, linking BIG1 to cholesterol efflux and lipid homeostasis.","evidence":"Vesicle co-IP, siRNA, surface biotinylation, cholesterol efflux assay, and GEF-dependent rescue","pmids":["23220274"],"confidence":"Medium","gaps":["Direct vs indirect role of ARF1 on ABCA1 itinerary not fully separated","In vivo lipid phenotype not tested"]},{"year":2013,"claim":"Positioned BIG1/BIG2 downstream of GBF1 in a sequential GEF cascade, with GBF1-activated ARF4/ARF5 recruiting them to the TGN.","evidence":"Dominant-negative/activated ARF mutants, GBF1 depletion, and immunoelectron microscopy","pmids":["23386609"],"confidence":"Medium","gaps":["Mechanistic coupling between ARF4/ARF5 and Arl1-mediated recruitment not integrated","Direct binding to ARF4/ARF5 not demonstrated"]},{"year":2013,"claim":"Established a catalysis-independent scaffolding role: BIG1/BIG2 assemble myosin IIA phosphatase complexes to control actomyosin dynamics and migration.","evidence":"Reciprocal endogenous co-IP, GEF-inactive C-terminal rescue, phospho-MLC blots, F-actin quantification, and migration assays","pmids":["23918382"],"confidence":"High","gaps":["Direct binding interfaces within the phosphatase complex not mapped","Relationship to the myosin IXb interaction not integrated"]},{"year":2013,"claim":"Demonstrated that BIG1 GEF activity is required for neuronal GABAA receptor surface trafficking and chloride conductance.","evidence":"BIG1–GABAAR co-IP, siRNA, dominant-negative E793K, surface quantification, and Cl- influx electrophysiology","pmids":["24198228"],"confidence":"Medium","gaps":["Trafficking step (forward vs recycling) not precisely localized","Subunit specificity of binding not fully defined"]},{"year":2013,"claim":"Linked BIG1 to neurite outgrowth through both GEF-dependent PI3K-AKT and partially GEF-independent ERK signaling.","evidence":"siRNA, BFA, dominant-negative and wild-type overexpression with phospho-pathway readouts and neurite measurements","pmids":["24090963"],"confidence":"Medium","gaps":["How a GEF connects to ERK independent of catalysis unexplained","Direct signaling intermediates not identified"]},{"year":2016,"claim":"Connected BIG1 trafficking function to Wnt signaling by showing it binds β-catenin and controls its PKA-dependent S675 phosphorylation and transcriptional activity.","evidence":"Yeast two-hybrid, in vitro binding, co-IP, GEF-inactive mutants, reporter assays, and PLD dependence","pmids":["27162341"],"confidence":"Medium","gaps":["Whether β-catenin is trafficking cargo or signaling partner not resolved","In vivo Wnt-pathway relevance untested"]},{"year":2016,"claim":"Implicated BIG1 in TNFR1 signaling by showing it is required for TRAF2 recruitment to complexes I and II and modulates JNK activation and apoptosis.","evidence":"siRNA, TNFR1 complex IP, TRAF2 ubiquitination assay, JNK blots, and apoptosis assays","pmids":["27834853"],"confidence":"Medium","gaps":["Direct vs trafficking-mediated role in complex assembly unresolved","Whether GEF activity is required not tested"]},{"year":2017,"claim":"Demonstrated that BIG1 is essential in vivo for deep-layer cortical neuron survival, polarization, and axon guidance.","evidence":"Full BIG1 knockout mice with immunohistochemistry, migration assays, primary neuron polarization, and glutamate challenge","pmids":["28414797"],"confidence":"Medium","gaps":["Molecular trafficking defect underlying neuron death not pinpointed","Cell-autonomy of axon guidance defects not fully separated"]},{"year":2018,"claim":"Defined the effector pathway for BIG1 in myelination, showing ARF1/AP-1-dependent (not GGA1 or COPI) trafficking is required for Schwann cell myelin formation.","evidence":"Schwann-cell-specific conditional KO of BIG1 and Arf1, EM, P0 immunofluorescence, and Arf1–adaptor co-IP","pmids":["29740613"],"confidence":"High","gaps":["Specific myelin cargo trafficked via this pathway beyond P0 not enumerated","Generalizability to CNS myelination untested"]},{"year":2019,"claim":"Established the disease-relevant mechanism of haploinsufficiency, linking altered recycling endosome composition to reduced surface GABAA receptors and lowered seizure threshold.","evidence":"Heterozygous frameshift mouse, hippocampal neuron culture, endosome marker and surface GABAAR quantification, and PTZ seizure assay","pmids":["31678406"],"confidence":"Medium","gaps":["Absence of spontaneous seizures leaves full human-phenotype recapitulation incomplete","Mechanism diverting GABAAR to lysosomes not detailed"]},{"year":2020,"claim":"Defined a pro-inflammatory signaling mechanism in which BIG1 activates ARF3 to drive PIP5K-mediated PI(4,5)P2 synthesis and TIRAP recruitment, amplifying TLR4 signaling in sepsis.","evidence":"Myeloid-specific conditional KO in LPS and CLP models, ARF3 activation, PI(4,5)P2 and TIRAP recruitment assays, and pathway blots","pmids":["32415087"],"confidence":"Medium","gaps":["Spatial site of ARF3 activation (Golgi vs plasma membrane) not resolved","Whether ARF3 selectivity over ARF1 is intrinsic to BIG1 untested"]},{"year":2022,"claim":"Identified 14-3-3ζ as a regulator that stabilizes BIG1 surface expression and its interaction with GABAA receptors to control chloride conductance.","evidence":"In vitro and in vivo co-IP, siRNA, overexpression, surface quantification, and Cl- influx assay in hippocampal neurons","pmids":["36562883"],"confidence":"Medium","gaps":["Whether 14-3-3ζ binding is phospho-dependent (e.g. via Ser-883) not tested","Mechanism of surface stabilization unresolved"]},{"year":2022,"claim":"Placed BIG1 downstream of KLF4 transcriptional control and within a PI3K/Akt/NF-κB axis driving microglial neuroinflammation.","evidence":"ChIP-qPCR, dual-luciferase reporter, siRNA, PI3K-agonist rescue, and migration/cytokine assays","pmids":["35090882"],"confidence":"Medium","gaps":["Whether BIG1 GEF activity mediates the inflammatory phenotype not tested","Direct molecular link to NF-κB not established"]},{"year":null,"claim":"How BIG1's distinct functional modes — Golgi GEF catalysis, GEF-independent scaffolding of myosin phosphatase, and nuclear/nucleolar association — are coordinated within a single protein, and what governs ARF-isoform selectivity across these contexts, remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model integrating the catalytic, scaffolding, and nuclear functions","Mechanism of context-specific ARF1 vs ARF3 selection unknown","Direct nuclear molecular activity uncharacterized"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,12,5]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,3,5]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[15,19]}],"localization":[{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[0,11,12,14]},{"term_id":"GO:0005730","term_label":"nucleolus","supporting_discovery_ids":[2,8]},{"term_id":"GO:0005635","term_label":"nuclear envelope","supporting_discovery_ids":[2,8]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[2,4]}],"pathway":[{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[9,13,21]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[19,23]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[18,23,25]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[20,21]}],"complexes":["myosin phosphatase complex (myosin IIA / PP1δ / MYPT1)","BIG1 homodimer/BIG-GBF1 dimer (DCB-HUS)","PDE3A-containing AKAP complex"],"partners":["ARF1","ARL1","MYO9B","MYH9","FKBP13","CTNNB1","TRAF2","YWHAZ"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9Y6D6","full_name":"Brefeldin A-inhibited guanine nucleotide-exchange protein 1","aliases":["ADP-ribosylation factor guanine nucleotide-exchange factor 1","p200 ARF guanine nucleotide exchange factor","p200 ARF-GEP1"],"length_aa":1849,"mass_kda":208.8,"function":"Promotes guanine-nucleotide exchange on ARF1 and ARF3. Promotes the activation of ARF1/ARF3 through replacement of GDP with GTP. Involved in vesicular trafficking. Required for the maintenance of Golgi structure; the function may be independent of its GEF activity. Required for the maturation of integrin beta-1 in the Golgi. Involved in the establishment and persistence of cell polarity during directed cell movement in wound healing. Proposed to act as A kinase-anchoring protein (AKAP) and may mediate crosstalk between Arf and PKA pathways. Inhibits GAP activity of MYO9B probably through competitive RhoA binding. The function in the nucleus remains to be determined","subcellular_location":"Cytoplasm; Cytoplasm, perinuclear region; Golgi apparatus; Golgi apparatus, trans-Golgi network membrane; Nucleus; Nucleus, nucleolus; Nucleus matrix","url":"https://www.uniprot.org/uniprotkb/Q9Y6D6/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ARFGEF1","classification":"Not Classified","n_dependent_lines":21,"n_total_lines":1208,"dependency_fraction":0.0173841059602649},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000066777","cell_line_id":"CID000803","localizations":[{"compartment":"golgi","grade":3},{"compartment":"vesicles","grade":3},{"compartment":"cytoplasmic","grade":2}],"interactors":[{"gene":"AKAP10","stoichiometry":10.0},{"gene":"DPY30","stoichiometry":10.0},{"gene":"ARFGEF2","stoichiometry":4.0},{"gene":"MSH2","stoichiometry":0.2},{"gene":"C13ORF34;BORA","stoichiometry":0.2},{"gene":"MYCBP","stoichiometry":0.2},{"gene":"MSH6","stoichiometry":0.2},{"gene":"TATDN3","stoichiometry":0.2},{"gene":"DNAJC13","stoichiometry":0.2},{"gene":"TMEM87A","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID000803","total_profiled":1310},"omim":[{"mim_id":"619964","title":"DEVELOPMENTAL DELAY, IMPAIRED SPEECH, AND BEHAVIORAL ABNORMALITIES, WITH OR WITHOUT SEIZURES; DEDISB","url":"https://www.omim.org/entry/619964"},{"mim_id":"616880","title":"TBC1 DOMAIN FAMILY, MEMBER 22B; TBC1D22B","url":"https://www.omim.org/entry/616880"},{"mim_id":"616879","title":"TBC1 DOMAIN FAMILY, MEMBER 22A; TBC1D22A","url":"https://www.omim.org/entry/616879"},{"mim_id":"616822","title":"MON2, REGULATOR OF ENDOSOME-TO-GOLGI TRAFFICKING; MON2","url":"https://www.omim.org/entry/616822"},{"mim_id":"606809","title":"ACYL-CoA-BINDING DOMAIN-CONTAINING PROTEIN 3; ACBD3","url":"https://www.omim.org/entry/606809"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Golgi apparatus","reliability":"Enhanced"},{"location":"Nucleoplasm","reliability":"Additional"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/ARFGEF1"},"hgnc":{"alias_symbol":["DKFZP434L057","BIG1","ARFGEP1","p200"],"prev_symbol":[]},"alphafold":{"accession":"Q9Y6D6","domains":[{"cath_id":"-","chopping":"2-54_66-203","consensus_level":"medium","plddt":80.9794,"start":2,"end":203},{"cath_id":"1.10.1000.11","chopping":"771-880","consensus_level":"high","plddt":86.6005,"start":771,"end":880},{"cath_id":"-","chopping":"1500-1543_1609-1835","consensus_level":"medium","plddt":86.1042,"start":1500,"end":1835}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9Y6D6","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y6D6-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y6D6-F1-predicted_aligned_error_v6.png","plddt_mean":75.44},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ARFGEF1","jax_strain_url":"https://www.jax.org/strain/search?query=ARFGEF1"},"sequence":{"accession":"Q9Y6D6","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9Y6D6.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9Y6D6/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9Y6D6"}},"corpus_meta":[{"pmid":"8586965","id":"PMC_8586965","title":"Overlapping and differential expression of BIG-2, BIG-1, TAG-1, and F3: four members of an axon-associated cell adhesion molecule subgroup of the immunoglobulin superfamily.","date":"1995","source":"Journal of neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/8586965","citation_count":142,"is_preprint":false},{"pmid":"10393931","id":"PMC_10393931","title":"p200 ARF-GEP1: a Golgi-localized guanine nucleotide exchange protein whose Sec7 domain is targeted by the drug brefeldin A.","date":"1999","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/10393931","citation_count":106,"is_preprint":false},{"pmid":"8060619","id":"PMC_8060619","title":"BIG-1: a new TAG-1/F3-related member of the immunoglobulin superfamily with neurite outgrowth-promoting activity.","date":"1994","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/8060619","citation_count":94,"is_preprint":false},{"pmid":"18417613","id":"PMC_18417613","title":"Redundant roles of BIG2 and BIG1, guanine-nucleotide exchange factors for ADP-ribosylation factors in membrane traffic between the trans-Golgi network and endosomes.","date":"2008","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/18417613","citation_count":75,"is_preprint":false},{"pmid":"23386609","id":"PMC_23386609","title":"The Sec7 guanine nucleotide exchange factor GBF1 regulates membrane recruitment of BIG1 and BIG2 guanine nucleotide exchange factors to the trans-Golgi network (TGN).","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23386609","citation_count":66,"is_preprint":false},{"pmid":"22291037","id":"PMC_22291037","title":"The small G protein Arl1 directs the trans-Golgi-specific targeting of the Arf1 exchange factors BIG1 and BIG2.","date":"2012","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/22291037","citation_count":57,"is_preprint":false},{"pmid":"35090882","id":"PMC_35090882","title":"The Novel KLF4/BIG1 Regulates LPS-mediated Neuro-inflammation and Migration in BV2 Cells via PI3K/Akt/NF-kB Signaling Pathway.","date":"2022","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/35090882","citation_count":50,"is_preprint":false},{"pmid":"26473412","id":"PMC_26473412","title":"MicroRNA-27b suppresses tumor progression by regulating ARFGEF1 and focal adhesion signaling.","date":"2015","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/26473412","citation_count":45,"is_preprint":false},{"pmid":"17360629","id":"PMC_17360629","title":"Regulation of brefeldin A-inhibited guanine nucleotide-exchange protein 1 (BIG1) and BIG2 activity via PKA and protein phosphatase 1gamma.","date":"2007","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/17360629","citation_count":45,"is_preprint":false},{"pmid":"17640864","id":"PMC_17640864","title":"Interactions between conserved domains within homodimers in the BIG1, BIG2, and GBF1 Arf guanine nucleotide exchange factors.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17640864","citation_count":43,"is_preprint":false},{"pmid":"30814512","id":"PMC_30814512","title":"miR-215 suppresses papillary thyroid cancer proliferation, migration, and invasion through the AKT/GSK-3β/Snail signaling by targeting ARFGEF1.","date":"2019","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/30814512","citation_count":42,"is_preprint":false},{"pmid":"29740613","id":"PMC_29740613","title":"BIG1/Arfgef1 and Arf1 regulate the initiation of myelination by Schwann cells in mice.","date":"2018","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/29740613","citation_count":38,"is_preprint":false},{"pmid":"17227842","id":"PMC_17227842","title":"BIG1, a brefeldin A-inhibited guanine nucleotide-exchange protein, is required for correct glycosylation and function of integrin beta1.","date":"2007","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/17227842","citation_count":38,"is_preprint":false},{"pmid":"20360857","id":"PMC_20360857","title":"Specific functions of BIG1 and BIG2 in endomembrane organization.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/20360857","citation_count":37,"is_preprint":false},{"pmid":"12606707","id":"PMC_12606707","title":"Interaction of FK506-binding protein 13 with brefeldin A-inhibited guanine nucleotide-exchange protein 1 (BIG1): effects of FK506.","date":"2003","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12606707","citation_count":35,"is_preprint":false},{"pmid":"33539420","id":"PMC_33539420","title":"CircRNA ARFGEF1 functions as a ceRNA to promote oncogenic KSHV-encoded viral interferon regulatory factor induction of cell invasion and angiogenesis by upregulating glutaredoxin 3.","date":"2021","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/33539420","citation_count":31,"is_preprint":false},{"pmid":"29125885","id":"PMC_29125885","title":"MiR 376c inhibits osteoblastogenesis by targeting Wnt3 and ARF-GEF-1 -facilitated augmentation of beta-catenin transactivation.","date":"2017","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29125885","citation_count":31,"is_preprint":false},{"pmid":"14973189","id":"PMC_14973189","title":"Nuclear localization and molecular partners of BIG1, a brefeldin A-inhibited guanine nucleotide-exchange protein for ADP-ribosylation factors.","date":"2004","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/14973189","citation_count":28,"is_preprint":false},{"pmid":"15644318","id":"PMC_15644318","title":"BIG1 is a binding partner of myosin IXb and regulates its Rho-GTPase activating protein activity.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15644318","citation_count":26,"is_preprint":false},{"pmid":"23918382","id":"PMC_23918382","title":"Arf guanine nucleotide-exchange factors BIG1 and BIG2 regulate nonmuscle myosin IIA activity by anchoring myosin phosphatase complex.","date":"2013","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/23918382","citation_count":25,"is_preprint":false},{"pmid":"19332778","id":"PMC_19332778","title":"Interaction of phosphodiesterase 3A with brefeldin A-inhibited guanine nucleotide-exchange proteins BIG1 and BIG2 and effect on ARF1 activity.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19332778","citation_count":24,"is_preprint":false},{"pmid":"24090963","id":"PMC_24090963","title":"BIG1, a brefeldin A-inhibited guanine nucleotide-exchange protein regulates neurite development via PI3K-AKT and ERK signaling pathways.","date":"2013","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/24090963","citation_count":24,"is_preprint":false},{"pmid":"23220274","id":"PMC_23220274","title":"BIG1, a brefeldin A-inhibited guanine nucleotide-exchange protein modulates ATP-binding cassette transporter A-1 trafficking and function.","date":"2012","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/23220274","citation_count":21,"is_preprint":false},{"pmid":"32415087","id":"PMC_32415087","title":"BIG1 controls macrophage pro-inflammatory responses through ARF3-mediated PI(4,5)P2 synthesis.","date":"2020","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/32415087","citation_count":20,"is_preprint":false},{"pmid":"18292223","id":"PMC_18292223","title":"Association of guanine nucleotide-exchange protein BIG1 in HepG2 cell nuclei with nucleolin, U3 snoRNA, and fibrillarin.","date":"2008","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/18292223","citation_count":20,"is_preprint":false},{"pmid":"27162341","id":"PMC_27162341","title":"Enhancement of β-catenin activity by BIG1 plus BIG2 via Arf activation and cAMP signals.","date":"2016","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/27162341","citation_count":20,"is_preprint":false},{"pmid":"21871176","id":"PMC_21871176","title":"Downregulation of ARFGEF1 and CAMK2B by promoter hypermethylation in breast cancer cells.","date":"2011","source":"BMB reports","url":"https://pubmed.ncbi.nlm.nih.gov/21871176","citation_count":19,"is_preprint":false},{"pmid":"16467138","id":"PMC_16467138","title":"Effect of protein kinase A on accumulation of brefeldin A-inhibited guanine nucleotide-exchange protein 1 (BIG1) in HepG2 cell nuclei.","date":"2006","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16467138","citation_count":19,"is_preprint":false},{"pmid":"27834853","id":"PMC_27834853","title":"Brefeldin A-Inhibited Guanine Nucleotide-Exchange Factor 1 (BIG1) Governs the Recruitment of Tumor Necrosis Factor Receptor-Associated Factor 2 (TRAF2) to Tumor Necrosis Factor Receptor 1 (TNFR1) Signaling Complexes.","date":"2016","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/27834853","citation_count":16,"is_preprint":false},{"pmid":"34113008","id":"PMC_34113008","title":"Haploinsufficiency of ARFGEF1 is associated with developmental delay, intellectual disability, and epilepsy with variable expressivity.","date":"2021","source":"Genetics in medicine : official journal of the American College of Medical Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/34113008","citation_count":15,"is_preprint":false},{"pmid":"34153089","id":"PMC_34153089","title":"BIG1 mediates sepsis-induced lung injury by modulating lipid raft-dependent macrophage inflammatory responses.","date":"2021","source":"Acta biochimica et biophysica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/34153089","citation_count":15,"is_preprint":false},{"pmid":"34854069","id":"PMC_34854069","title":"Circ_0059354 aggravates the progression of papillary thyroid carcinoma by elevating ARFGEF1 through sponging miR-766-3p.","date":"2021","source":"Journal of endocrinological investigation","url":"https://pubmed.ncbi.nlm.nih.gov/34854069","citation_count":14,"is_preprint":false},{"pmid":"16413268","id":"PMC_16413268","title":"BIG1 and BIG2, brefeldin A-inhibited guanine nucleotide-exchange factors for ADP-ribosylation factors.","date":"2005","source":"Methods in enzymology","url":"https://pubmed.ncbi.nlm.nih.gov/16413268","citation_count":14,"is_preprint":false},{"pmid":"31678406","id":"PMC_31678406","title":"Arfgef1 haploinsufficiency in mice alters neuronal endosome composition and decreases membrane surface postsynaptic GABAA receptors.","date":"2019","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/31678406","citation_count":11,"is_preprint":false},{"pmid":"28414797","id":"PMC_28414797","title":"BIG1 is required for the survival of deep layer neurons, neuronal polarity, and the formation of axonal tracts between the thalamus and neocortex in developing brain.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/28414797","citation_count":11,"is_preprint":false},{"pmid":"31199673","id":"PMC_31199673","title":"Involvement of BIG1 and BIG2 in regulating VEGF expression and angiogenesis.","date":"2019","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/31199673","citation_count":9,"is_preprint":false},{"pmid":"35048795","id":"PMC_35048795","title":"The miR-133b/brefeldin A-inhibited guanine nucleotide-exchange protein 1 (ARFGEF1) axis represses proliferation, invasion, and migration in cervical cancer cells.","date":"2022","source":"Bioengineered","url":"https://pubmed.ncbi.nlm.nih.gov/35048795","citation_count":9,"is_preprint":false},{"pmid":"24198228","id":"PMC_24198228","title":"BIG1, a brefeldin A-inhibited guanine nucleotide-exchange factor, is required for GABA-gated Cl⁻ influx through regulation of GABAA receptor trafficking.","date":"2013","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/24198228","citation_count":9,"is_preprint":false},{"pmid":"35782386","id":"PMC_35782386","title":"Expanding the Phenotypic and Genotypic Spectrum of ARFGEF1-Related Neurodevelopmental Disorder.","date":"2022","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/35782386","citation_count":3,"is_preprint":false},{"pmid":"36562883","id":"PMC_36562883","title":"14-3-3ζ Mediates GABAAR Activation by Interacting with BIG1.","date":"2022","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/36562883","citation_count":3,"is_preprint":false},{"pmid":"39259764","id":"PMC_39259764","title":"Big1 is a newly identified autophagy regulator that is critical for a fully functional V-ATPase.","date":"2024","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/39259764","citation_count":2,"is_preprint":false},{"pmid":"41574444","id":"PMC_41574444","title":"Distinct membrane trafficking pathways defined by the requirement for GNOM or BIG1 to BIG4 mediate preinvasive immunity toward filamentous fungal pathogens.","date":"2026","source":"The New phytologist","url":"https://pubmed.ncbi.nlm.nih.gov/41574444","citation_count":1,"is_preprint":false},{"pmid":"40777362","id":"PMC_40777362","title":"Big1 is a cell cycle regulator linking cell size to basal body number.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/40777362","citation_count":0,"is_preprint":false},{"pmid":"41875877","id":"PMC_41875877","title":"Big1 is a cell-cycle regulator linking cell size to basal body number in Tetrahymena thermophila.","date":"2026","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/41875877","citation_count":0,"is_preprint":false},{"pmid":"42201909","id":"PMC_42201909","title":"Correction: CircRNA ARFGEF1 functions as a ceRNA to promote oncogenic KSHV-encoded viral interferon regulatory factor induction of cell invasion and angiogenesis by upregulating glutaredoxin 3.","date":"2026","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/42201909","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":25186,"output_tokens":7087,"usd":0.090931,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":16234,"output_tokens":7392,"usd":0.132985,"stage2_stop_reason":"end_turn"},"total_usd":0.223916,"stage1_batch_id":"msgbatch_0179Z2pxRYBsXi2xADneafRw","stage2_batch_id":"msgbatch_01LaY9ZaVdgjWArcZo9eqQE5","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"Human p200 ARF-GEP1 (ARFGEF1) is a Golgi-localized guanine nucleotide exchange factor whose Sec7 domain catalyzes GTP loading onto class I ARFs; brefeldin A acts as an uncompetitive inhibitor targeting the p200-ARF complex (Ki ~7 µM) rather than competing with ARF for p200 binding. Golgi localization signal maps to the N-terminal third of the protein.\",\n      \"method\": \"GTPγS loading assay (in vitro GEF activity), kinetic inhibition analysis, tagged-protein cellular localization by immunofluorescence, truncation mapping\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro enzymatic reconstitution with kinetic analysis and truncation mapping, replicated across multiple constructs\",\n      \"pmids\": [\"10393931\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"The N-terminal region (aa 1–331) of BIG1 interacts with FK506-binding protein 13 (FKBP13); this association was confirmed by co-immunoprecipitation of endogenous BIG1 and FKBP13 from Jurkat T cells. FK506 treatment increased membrane binding of BIG1, BIG2, and ARF to Golgi and other membranes.\",\n      \"method\": \"Yeast two-hybrid screen, co-immunoprecipitation of endogenous proteins, in vitro membrane-binding assay with GTPγS\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — yeast two-hybrid plus reciprocal co-IP of endogenous proteins, single lab\",\n      \"pmids\": [\"12606707\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"BIG1 localizes to nuclei (nuclear envelope/nucleoli) in serum-starved HepG2 cells independently of BIG2; nuclear BIG1 co-immunoprecipitates with nucleoporin p62 and nucleolin, but ARF is not detected in nuclear BIG1 immunoprecipitates, indicating independent nuclear functions distinct from Golgi ARF activation.\",\n      \"method\": \"Confocal immunofluorescence microscopy, subcellular fractionation, Western blot, co-immunoprecipitation from purified nuclei\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (microscopy, fractionation, co-IP) in single lab\",\n      \"pmids\": [\"14973189\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"BIG1 directly binds to the zinc finger/GAP domain of myosin IXb and inhibits myosin IXb RhoA-GAP activity (IC50 ~0.06 µM) by competing with RhoA for the same binding region on myosin IXb.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation of endogenous proteins, in vitro direct binding with purified proteins, GAP activity assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with purified proteins plus enzymatic assay and endogenous co-IP; multiple orthogonal methods in one study\",\n      \"pmids\": [\"15644318\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"PKA-catalyzed phosphorylation of BIG1 at Ser-883 is required for cAMP-induced nuclear accumulation of BIG1; a functional nuclear localization signal (712KPK714) is also necessary. Microtubule integrity (nocodazole-sensitive) is required for translocation. BIG2 is not similarly regulated.\",\n      \"method\": \"Site-directed mutagenesis (S883A, S883D, NLS mutant), immunofluorescence microscopy, PKA inhibitor (H-89, PKI) treatments, nocodazole treatment\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mutagenesis of phosphorylation site and NLS with cellular functional readout, multiple orthogonal approaches in single rigorous study\",\n      \"pmids\": [\"16467138\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"PKA phosphorylates BIG1, significantly decreasing its GEF activity toward ARFs; protein phosphatase 1γ (but not PP1α, PP1β, or PP2A) reverses this phosphorylation and restores GEP activity. Endogenous PP1γ co-immunoprecipitates with BIG1 from microsomal fractions. Elevated cAMP induces PKA-catalyzed phosphorylation and nuclear accumulation of BIG1 but not BIG2.\",\n      \"method\": \"In vitro kinase assay with recombinant PKA, in vitro phosphatase assay with recombinant phosphatases, GEP activity assay from immunoprecipitated BIG1, co-immunoprecipitation, okadaic acid treatment\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro enzymatic assays (kinase, phosphatase, GEF) combined with endogenous co-IP; multiple orthogonal methods in one rigorous study\",\n      \"pmids\": [\"17360629\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"BIG1 is required for correct N-glycosylation of integrin β1 in the Golgi; BIG1 siRNA (but not BIG2 siRNA) causes aberrant electrophoretic mobility of β1, decreased active RhoA-GTP, impaired cell spreading, adhesion, and migration. Overexpression of HA-BIG1 restores RhoA-GTP levels.\",\n      \"method\": \"siRNA knockdown, PNGase F and EndoH glycosidase digestion, Western blot, electron microscopy (Golgi morphology), immunofluorescence, RhoA pull-down activity assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (glycosidase treatment, EM, activity assay, rescue by OE) in single lab\",\n      \"pmids\": [\"17227842\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"BIG1 and BIG2 form homodimers through interactions between their conserved DCB domains; within each homodimer the DCB domain also interacts with the HUS domain via the HUS box. Both DCB and HUS domains are necessary for GBF1 dimerization in mammalian cells; the DCB domain is essential for yeast viability.\",\n      \"method\": \"Yeast two-hybrid assay, biochemical in vitro interaction assays, mammalian cell dimerization assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — yeast two-hybrid plus biochemical assays plus cellular assay; single lab with orthogonal methods\",\n      \"pmids\": [\"17640864\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"BIG1 in nuclei of HepG2 cells associates with nucleolin, U3 snoRNA, and fibrillarin, dependent on nucleic acids (RNase A/DNase-sensitive); BIG1 and nucleolin also associate with nucleoporin p62 at the nuclear envelope, suggesting BIG1 participates in dynamic nucleolar complexes.\",\n      \"method\": \"Co-immunoprecipitation from purified nuclei, RNase/DNase sensitivity experiments, 32P RNA labeling, U3 snoRNA-specific hybridization\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP with nucleic acid dependency tested by enzymatic digestion, RNA identity confirmed by hybridization; single lab\",\n      \"pmids\": [\"18292223\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"BIG1 and BIG2 play redundant roles in membrane trafficking between the TGN and endosomes, including retrograde transport of furin from late endosomes to the TGN and maintenance of localization of TGN/recycling endosome proteins; this overlaps functionally with AP-1 clathrin adaptor activity.\",\n      \"method\": \"siRNA double knockdown (BIG1 and BIG2), immunofluorescence microscopy, protein localization assays, epistasis with AP-1 depletion\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis (double KD) with specific trafficking readout; single lab\",\n      \"pmids\": [\"18417613\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"PDE3A interacts with BIG1 and BIG2 as part of AKAP complexes; depletion or inhibition of PDE3A disperses BIG1/BIG2 from the perinuclear Golgi and decreases membrane-associated ARF1-GTP, suggesting PDE3A limits local cAMP to prevent PKA-mediated inhibition of BIG1/BIG2 GEF activity.\",\n      \"method\": \"siRNA depletion of PDE3A, cilostamide pharmacological inhibition, confocal immunofluorescence, ARF1-GTP pull-down assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional readout (ARF1-GTP levels, localization) with pharmacological and genetic perturbations; single lab\",\n      \"pmids\": [\"19332778\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"BIG1 (but not BIG2) depletion causes fragmentation of the Golgi apparatus into mini-stacks that remain polarized and functional for cargo export, demonstrating a non-redundant role for BIG1 in maintaining normal Golgi morphology.\",\n      \"method\": \"siRNA knockdown, fixed and live-cell fluorescence imaging, Golgi morphology analysis\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct comparative siRNA with cellular morphology readout; single lab\",\n      \"pmids\": [\"20360857\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"The Arf-like GTPase Arl1 directly binds the N-terminal region of BIG1/BIG2 (via their Drosophila ortholog Sec71) and is necessary for Golgi recruitment of BIG1 and BIG2 (but not GBF1) to the trans-Golgi in mammalian cells.\",\n      \"method\": \"Liposome-based affinity purification of Arl1 effectors, Drosophila Sec71 binding assay, mammalian Arl1 knockdown with BIG1/BIG2 localization readout\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro affinity purification (direct binding) plus cellular knockdown with localization readout; orthogonal methods across species\",\n      \"pmids\": [\"22291037\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"BIG1 associates with ABCA1 in vesicle preparations from rat liver; BIG1 depletion reduces surface ABCA1, inhibits its internalization and recycling, and decreases cholesterol efflux by ~60%. These effects depend on BIG1 GEF activity and ARF1 activation.\",\n      \"method\": \"Vesicle immunoprecipitation, siRNA knockdown, surface biotinylation/glutathione cleavage assay, cholesterol efflux assay, BIG1 overexpression rescue\",\n      \"journal\": \"Arteriosclerosis, thrombosis, and vascular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (vesicle co-IP, surface biotinylation, GEF-dependent rescue); single lab\",\n      \"pmids\": [\"23220274\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"GBF1-activated ARF4 and ARF5 (but not ARF3) facilitate recruitment of BIG1 and BIG2 to the TGN, defining a functional GEF cascade where GBF1 at the TGN acts upstream of BIG1/BIG2 recruitment. GBF1 localizes ultrastructurally to pre-Golgi, Golgi, and TGN.\",\n      \"method\": \"Dominant-negative and activated ARF mutants, siRNA depletion of GBF1, immunofluorescence and immunoelectron microscopy for BIG1/BIG2 localization\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis using ARF mutants and GEF depletion with localization readout; single lab\",\n      \"pmids\": [\"23386609\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"BIG1 and BIG2 form complexes with nonmuscle myosin IIA independently of their GEF catalytic activity (C-terminal sequences suffice for interaction); selective depletion of BIG1 or BIG2 enhances phosphorylation of myosin regulatory light chain (T18/S19) and F-actin content, impairing cell migration. BIG1/BIG2 scaffold myosin phosphatase complexes (including myosin IIA, PP1δ, and MYPT1) to regulate myosin IIA activity.\",\n      \"method\": \"Reciprocal co-immunoprecipitation of endogenous proteins, siRNA depletion, C-terminal rescue constructs (GEF-inactive), phospho-myosin light chain Western blot, F-actin quantification, Transwell migration assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal endogenous co-IP, GEF-activity-independent rescue, multiple cellular phenotypes (phosphorylation, actin, migration); single lab but multiple orthogonal methods and strong controls\",\n      \"pmids\": [\"23918382\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"BIG1 directly binds GABAA receptor subunits and is required for their trafficking to the neuronal cell surface via its GEF activity; BIG1 depletion or dominant-negative BIG1-E793K expression reduces surface GABAAR and suppresses GABA-gated chloride influx.\",\n      \"method\": \"Co-immunoprecipitation (BIG1–GABAAR), siRNA knockdown, dominant-negative overexpression, surface GABAAR quantification, electrophysiology (Cl− influx assay)\",\n      \"journal\": \"Molecular neurobiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP plus functional assay plus dominant-negative; single lab\",\n      \"pmids\": [\"24198228\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"BIG1 GEF activity regulates neurite development via PI3K-AKT signaling (GEF-activity-dependent) and ERK signaling (partially GEF-activity-independent); BIG1 colocalizes with synaptophysin and its expression increases during rat brain development.\",\n      \"method\": \"siRNA knockdown, brefeldin A inhibition, dominant-negative BIG1 overexpression, wild-type BIG1 overexpression, phospho-Western blot for PI3K/AKT/ERK, neurite length measurement, immunostaining\",\n      \"journal\": \"Neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple genetic/pharmacological perturbations with pathway-specific readouts; single lab\",\n      \"pmids\": [\"24090963\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"BIG1 directly interacts with β-catenin via its N-terminal sequence; depletion of BIG1 and/or BIG2 or GEF-inactive mutant expression causes β-catenin accumulation at perinuclear Golgi and reduces PKA-phosphorylated β-catenin (S675). BIG2 AKAP-C sequence is required for PKA-mediated S675 phosphorylation and β-catenin transcription coactivator function. Effects require phospholipase D activity and vesicular trafficking.\",\n      \"method\": \"Yeast two-hybrid, in vitro synthesized protein binding, co-immunoprecipitation, siRNA depletion, GEF-inactive mutant, immunofluorescence, phospho-Western blot, transcriptional reporter assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — yeast two-hybrid plus in vitro binding plus co-IP plus functional readouts; single lab\",\n      \"pmids\": [\"27162341\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"BIG1 is required for recruitment of TRAF2 to TNFR1 signaling complex (complex I) and to the death-inducing signaling complex (complex II) after TNF-α stimulation; BIG1 knockdown attenuates TNF-α-induced TRAF2 ubiquitination and JNK activation, and increases apoptosis sensitivity.\",\n      \"method\": \"siRNA knockdown, TNF-α stimulation, TNFR1 complex immunoprecipitation, TRAF2 ubiquitination assay, JNK activation Western blot, apoptosis assay\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — complex immunoprecipitation with ubiquitination and kinase activity readouts; single lab\",\n      \"pmids\": [\"27834853\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"BIG1 loss in mice causes apoptosis of Tbr1+/Ctip2+ deep-layer neurons in a spatial-temporal pattern, impairs neuronal polarization in vitro, renders neurons hypersensitive to glutamate-induced apoptosis, and causes ectopic corticothalamic axon projections and failure of thalamocortical axons to cross the DTB.\",\n      \"method\": \"BIG1 knockout mouse (full KO), immunohistochemistry, pulse-chase migration assay, primary neuron culture, in vitro polarization assay, low-dose glutamate challenge\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO with multiple cellular and in vivo phenotype readouts; single lab\",\n      \"pmids\": [\"28414797\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"BIG1/Arfgef1 and its effector Arf1 are required for initiation of myelination by Schwann cells; Schwann cell-specific BIG1 conditional KO mice show reduced myelin thickness and decreased myelin protein zero (P0) in the myelin membrane. BIG1 KO specifically reduces Arf1 association with AP-1 clathrin adaptor subunits (but not GGA1 or COPI), indicating AP-1-dependent trafficking is the relevant effector pathway.\",\n      \"method\": \"Schwann cell-specific conditional KO mouse (BIG1 and Arf1), electron microscopy (myelin thickness), immunofluorescence (P0 localization), co-immunoprecipitation (Arf1 with AP-1, GGA1, COPI subunits), Western blot\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cell-type-specific conditional KO with ultrastructural readout, mechanistic dissection of effector pathway by co-IP; replicated with parallel Arf1 conditional KO\",\n      \"pmids\": [\"29740613\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Arfgef1 haploinsufficiency in mice alters neuronal endosome composition (altered ratio of Arf6+:Rab11+:TrfR+ recycling endosomes) and reduces dendritic surface and synaptic GABAA receptor levels (with increased lysosomal targeting), resulting in decreased seizure threshold but no spontaneous seizures.\",\n      \"method\": \"Heterozygous frameshift mouse model, primary hippocampal neuron culture, surface/synaptic GABAAR immunostaining, endosome marker quantification, pentylenetetrazol seizure threshold assay\",\n      \"journal\": \"Neurobiology of disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mouse haploinsufficiency model with mechanistic trafficking readouts; single lab\",\n      \"pmids\": [\"31678406\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"BIG1 promotes macrophage pro-inflammatory responses in sepsis via ARF3 activation, which stimulates PIP5K-mediated PI(4,5)P2 synthesis and TIRAP recruitment to the plasma membrane, thereby activating TLR4-MyD88 signaling. Myeloid-specific BIG1 cKO reduces sepsis mortality and organ damage.\",\n      \"method\": \"Myeloid-specific BIG1 conditional KO mouse (LPS and CLP models), bone marrow-derived macrophage cultures, ARF3 activation assay, PI(4,5)P2 measurement, TIRAP membrane recruitment assay, TLR4/MyD88/NF-κB pathway Western blot, cytokine ELISA\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO mouse with mechanistic pathway dissection (ARF3→PIP5K→PI(4,5)P2→TIRAP); multiple methods, single lab\",\n      \"pmids\": [\"32415087\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"14-3-3ζ interacts with both GABAA receptor β subunit and BIG1 in vitro and in vivo (hippocampal neurons); overexpression of 14-3-3ζ increases BIG1 surface expression and BIG1–GABAAR interaction, while 14-3-3ζ depletion reduces surface expression of both BIG1 and GABAAR and suppresses GABA-gated chloride influx.\",\n      \"method\": \"Co-immunoprecipitation (in vitro and in vivo), siRNA depletion, overexpression, immunofluorescence, surface expression quantification, Cl− influx assay\",\n      \"journal\": \"Molecular neurobiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro and in vivo co-IP plus functional ion channel readout; single lab\",\n      \"pmids\": [\"36562883\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"KLF4 transcriptionally activates BIG1 (ARFGEF1) by binding its promoter (confirmed by ChIP-qPCR and dual-luciferase reporter assay); BIG1 mediates LPS-induced microglial neuroinflammation and migration via the PI3K/Akt/NF-κB pathway.\",\n      \"method\": \"ChIP-qPCR, dual-luciferase reporter assay, siRNA knockdown, PI3K agonist (740Y-P) rescue, RT-qPCR, ELISA, Transwell migration assay, Western blot\",\n      \"journal\": \"Neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and luciferase assay confirm promoter binding; pathway placement by pharmacological rescue; single lab\",\n      \"pmids\": [\"35090882\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ARFGEF1/BIG1 is a ~200 kDa Golgi-localized guanine nucleotide exchange factor that activates class I ARFs (ARF1, ARF3) via its Sec7 domain (inhibited uncompetitively by brefeldin A); it is recruited to the trans-Golgi by Arl1 (downstream of GBF1-activated ARFs) and regulates AP-1-dependent vesicular trafficking between the TGN and endosomes, Golgi morphology maintenance, integrin β1 glycosylation, ABCA1 and GABAA receptor surface trafficking, and myelination initiation in Schwann cells; beyond its GEF activity, BIG1 scaffolds myosin phosphatase complexes (with myosin IIA, PP1δ, MYPT1) to control actomyosin dynamics and cell migration, interacts with myosin IXb to inhibit its RhoA-GAP activity, associates with TRAF2 to support TNFR1 signaling, binds β-catenin and FKBP13, and undergoes PKA-catalyzed phosphorylation at Ser-883 (reversed by PP1γ) that both reduces its GEF activity and drives nuclear translocation via an NLS and microtubules, where it associates with nucleolin, U3 snoRNA, and fibrillarin in nucleolar complexes; in macrophages, BIG1 promotes pro-inflammatory TLR4 signaling through ARF3-dependent PI(4,5)P2 synthesis and TIRAP membrane recruitment, and haploinsufficiency in humans causes autosomal dominant neurodevelopmental disorder with epilepsy attributed to impaired vesicle trafficking affecting neuronal GABAA receptor surface expression.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"ARFGEF1/BIG1 is a Golgi-localized guanine nucleotide exchange factor that activates class I ARFs via its Sec7 domain to drive vesicular trafficking, with brefeldin A acting as an uncompetitive inhibitor of the BIG1–ARF complex [#0]. It is recruited to the trans-Golgi by the Arf-like GTPase Arl1 binding its N-terminal region [#12], downstream of a GEF cascade in which GBF1-activated ARF4/ARF5 promote BIG1/BIG2 TGN recruitment [#14], where BIG1 acts redundantly with BIG2 in AP-1-dependent transport between the TGN and endosomes [#9] while non-redundantly maintaining Golgi morphology [#11]. Through its GEF activity BIG1 controls surface trafficking of multiple cargoes, including integrin β1 glycosylation and RhoA activation [#6], ABCA1 recycling and cholesterol efflux [#13], and neuronal GABAA receptor surface expression [#16]. Its catalytic activity is subject to a cAMP/PKA switch: PKA phosphorylates Ser-883 to reduce GEF activity and is reversed by PP1γ [#5], while PDE3A-containing AKAP complexes limit local cAMP to sustain ARF1 activation [#10]; the same phosphorylation, together with an NLS and intact microtubules, drives nuclear/nucleolar translocation where BIG1 associates with nucleolin, U3 snoRNA, and fibrillarin [#4, #8]. Beyond catalysis, BIG1 scaffolds nonmuscle myosin IIA phosphatase complexes (with PP1δ and MYPT1) to regulate actomyosin dynamics and cell migration [#15] and binds myosin IXb to inhibit its RhoA-GAP activity [#3]. In immune and neural contexts it promotes pro-inflammatory TLR4 signaling via ARF3-dependent PI(4,5)P2 synthesis and TIRAP recruitment [#23], supports TNFR1 complex assembly through TRAF2 recruitment [#19], and is required for Schwann cell myelination through ARF1/AP-1-dependent trafficking [#21]. Loss-of-function studies establish that BIG1 is essential for cortical neuron survival and axon guidance [#20], and haploinsufficiency reduces seizure threshold via impaired GABAA receptor trafficking [#22].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Established the core biochemical identity of BIG1 as a brefeldin-A-sensitive ARF guanine nucleotide exchange factor, answering what enzymatic activity the protein carries and where it acts.\",\n      \"evidence\": \"In vitro GTPγS loading assays with kinetic inhibition analysis and truncation mapping of the Golgi localization signal\",\n      \"pmids\": [\"10393931\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify upstream recruiters or downstream trafficking cargoes\", \"ARF isoform selectivity in vivo not resolved\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Identified the first physical interaction partner (FKBP13) and linked immunophilin signaling to BIG1 membrane association.\",\n      \"evidence\": \"Yeast two-hybrid and reciprocal co-IP of endogenous proteins from Jurkat cells with GTPγS membrane-binding assay\",\n      \"pmids\": [\"12606707\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of the BIG1–FKBP13 interaction unresolved\", \"Single lab, no in vivo phenotype\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Revealed a GEF-independent function by showing BIG1 directly inhibits myosin IXb RhoA-GAP activity, connecting BIG1 to Rho-GTPase regulation.\",\n      \"evidence\": \"Yeast two-hybrid, direct binding of purified proteins, GAP activity assay, endogenous co-IP\",\n      \"pmids\": [\"15644318\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cellular RhoA-pathway consequence not demonstrated in this study\", \"Structural basis of competition with RhoA not defined\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Demonstrated that BIG1 has a nuclear/nucleolar pool distinct from its Golgi ARF-activation role, since nuclear BIG1 lacked associated ARF but bound nucleolin and nucleoporin p62.\",\n      \"evidence\": \"Confocal microscopy, subcellular fractionation, and co-IP from purified nuclei of serum-starved HepG2 cells\",\n      \"pmids\": [\"14973189\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular function of nuclear BIG1 not established\", \"Trigger for nuclear pool size not quantified\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Defined the mechanism of nuclear translocation, showing PKA phosphorylation at Ser-883 plus a functional NLS and microtubule integrity are required.\",\n      \"evidence\": \"Site-directed mutagenesis of S883 and NLS, immunofluorescence, PKA inhibitors, and nocodazole treatment\",\n      \"pmids\": [\"16467138\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Nuclear activity of translocated BIG1 not assayed\", \"Identity of nuclear import machinery beyond NLS not defined\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Connected the PKA phosphorylation switch to catalytic regulation, showing phosphorylation lowers GEF activity and PP1γ specifically reverses it.\",\n      \"evidence\": \"In vitro kinase, phosphatase, and GEF assays plus endogenous PP1γ co-IP from microsomes\",\n      \"pmids\": [\"17360629\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether GEF inhibition and nuclear translocation are coupled or separable not resolved\", \"Spatial coordination of the kinase/phosphatase not mapped\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Linked BIG1 GEF function to a specific cargo pathway, showing it is required for integrin β1 glycosylation, RhoA activation, and cell migration, non-redundantly with BIG2.\",\n      \"evidence\": \"siRNA knockdown, glycosidase digestion, EM, RhoA pull-down, and overexpression rescue\",\n      \"pmids\": [\"17227842\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct enzymatic step controlled by BIG1 in glycosylation not defined\", \"Link between Golgi trafficking and RhoA activation mechanistically incomplete\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Refined the nuclear function by placing BIG1 in nucleic-acid-dependent nucleolar complexes with nucleolin, U3 snoRNA, and fibrillarin.\",\n      \"evidence\": \"Co-IP from purified nuclei with RNase/DNase sensitivity and U3 snoRNA hybridization\",\n      \"pmids\": [\"18292223\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Role in rRNA processing or ribosome biogenesis not tested\", \"Whether GEF activity is involved in the nucleolus unknown\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Established the structural basis for BIG-protein dimerization through DCB–DCB and DCB–HUS interactions, defining how the GEF self-associates.\",\n      \"evidence\": \"Yeast two-hybrid, in vitro biochemical interaction, and mammalian dimerization assays\",\n      \"pmids\": [\"17640864\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of dimerization for GEF activity not quantified\", \"Hetero- vs homodimer preference in vivo unresolved\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Defined BIG1/BIG2 as redundant regulators of TGN–endosome trafficking acting in the AP-1 clathrin pathway, including furin retrograde transport.\",\n      \"evidence\": \"Double siRNA knockdown with trafficking readouts and AP-1 epistasis\",\n      \"pmids\": [\"18417613\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct mechanistic link between ARF activation and AP-1 recruitment not shown here\", \"Cargo specificity beyond furin not delineated\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Showed that PDE3A-containing AKAP complexes sustain BIG1/BIG2 GEF activity by limiting local cAMP, integrating the PKA switch with localized signaling.\",\n      \"evidence\": \"siRNA and pharmacological PDE3A inhibition, confocal microscopy, and ARF1-GTP pull-down\",\n      \"pmids\": [\"19332778\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct scaffolding architecture of the AKAP complex not resolved\", \"In vivo relevance not tested\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Distinguished a non-redundant role for BIG1 in maintaining Golgi morphology, separable from cargo export function.\",\n      \"evidence\": \"Comparative siRNA with fixed and live-cell Golgi imaging\",\n      \"pmids\": [\"20360857\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which BIG1 maintains ribbon integrity unknown\", \"Effector linking GEF activity to morphology not identified\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identified Arl1 as the direct recruiter of BIG1 to the trans-Golgi, answering how the GEF is targeted to membranes.\",\n      \"evidence\": \"Liposome affinity purification, Drosophila Sec71 binding, and Arl1 knockdown with localization readout across species\",\n      \"pmids\": [\"22291037\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How Arl1 binding relates to PKA-regulated cytosolic/nuclear pools unresolved\", \"Stoichiometry of recruitment not defined\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Extended the GEF-dependent cargo repertoire to ABCA1, linking BIG1 to cholesterol efflux and lipid homeostasis.\",\n      \"evidence\": \"Vesicle co-IP, siRNA, surface biotinylation, cholesterol efflux assay, and GEF-dependent rescue\",\n      \"pmids\": [\"23220274\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct vs indirect role of ARF1 on ABCA1 itinerary not fully separated\", \"In vivo lipid phenotype not tested\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Positioned BIG1/BIG2 downstream of GBF1 in a sequential GEF cascade, with GBF1-activated ARF4/ARF5 recruiting them to the TGN.\",\n      \"evidence\": \"Dominant-negative/activated ARF mutants, GBF1 depletion, and immunoelectron microscopy\",\n      \"pmids\": [\"23386609\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanistic coupling between ARF4/ARF5 and Arl1-mediated recruitment not integrated\", \"Direct binding to ARF4/ARF5 not demonstrated\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Established a catalysis-independent scaffolding role: BIG1/BIG2 assemble myosin IIA phosphatase complexes to control actomyosin dynamics and migration.\",\n      \"evidence\": \"Reciprocal endogenous co-IP, GEF-inactive C-terminal rescue, phospho-MLC blots, F-actin quantification, and migration assays\",\n      \"pmids\": [\"23918382\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct binding interfaces within the phosphatase complex not mapped\", \"Relationship to the myosin IXb interaction not integrated\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Demonstrated that BIG1 GEF activity is required for neuronal GABAA receptor surface trafficking and chloride conductance.\",\n      \"evidence\": \"BIG1–GABAAR co-IP, siRNA, dominant-negative E793K, surface quantification, and Cl- influx electrophysiology\",\n      \"pmids\": [\"24198228\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Trafficking step (forward vs recycling) not precisely localized\", \"Subunit specificity of binding not fully defined\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Linked BIG1 to neurite outgrowth through both GEF-dependent PI3K-AKT and partially GEF-independent ERK signaling.\",\n      \"evidence\": \"siRNA, BFA, dominant-negative and wild-type overexpression with phospho-pathway readouts and neurite measurements\",\n      \"pmids\": [\"24090963\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"How a GEF connects to ERK independent of catalysis unexplained\", \"Direct signaling intermediates not identified\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Connected BIG1 trafficking function to Wnt signaling by showing it binds β-catenin and controls its PKA-dependent S675 phosphorylation and transcriptional activity.\",\n      \"evidence\": \"Yeast two-hybrid, in vitro binding, co-IP, GEF-inactive mutants, reporter assays, and PLD dependence\",\n      \"pmids\": [\"27162341\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether β-catenin is trafficking cargo or signaling partner not resolved\", \"In vivo Wnt-pathway relevance untested\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Implicated BIG1 in TNFR1 signaling by showing it is required for TRAF2 recruitment to complexes I and II and modulates JNK activation and apoptosis.\",\n      \"evidence\": \"siRNA, TNFR1 complex IP, TRAF2 ubiquitination assay, JNK blots, and apoptosis assays\",\n      \"pmids\": [\"27834853\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct vs trafficking-mediated role in complex assembly unresolved\", \"Whether GEF activity is required not tested\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Demonstrated that BIG1 is essential in vivo for deep-layer cortical neuron survival, polarization, and axon guidance.\",\n      \"evidence\": \"Full BIG1 knockout mice with immunohistochemistry, migration assays, primary neuron polarization, and glutamate challenge\",\n      \"pmids\": [\"28414797\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular trafficking defect underlying neuron death not pinpointed\", \"Cell-autonomy of axon guidance defects not fully separated\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Defined the effector pathway for BIG1 in myelination, showing ARF1/AP-1-dependent (not GGA1 or COPI) trafficking is required for Schwann cell myelin formation.\",\n      \"evidence\": \"Schwann-cell-specific conditional KO of BIG1 and Arf1, EM, P0 immunofluorescence, and Arf1–adaptor co-IP\",\n      \"pmids\": [\"29740613\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific myelin cargo trafficked via this pathway beyond P0 not enumerated\", \"Generalizability to CNS myelination untested\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Established the disease-relevant mechanism of haploinsufficiency, linking altered recycling endosome composition to reduced surface GABAA receptors and lowered seizure threshold.\",\n      \"evidence\": \"Heterozygous frameshift mouse, hippocampal neuron culture, endosome marker and surface GABAAR quantification, and PTZ seizure assay\",\n      \"pmids\": [\"31678406\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Absence of spontaneous seizures leaves full human-phenotype recapitulation incomplete\", \"Mechanism diverting GABAAR to lysosomes not detailed\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Defined a pro-inflammatory signaling mechanism in which BIG1 activates ARF3 to drive PIP5K-mediated PI(4,5)P2 synthesis and TIRAP recruitment, amplifying TLR4 signaling in sepsis.\",\n      \"evidence\": \"Myeloid-specific conditional KO in LPS and CLP models, ARF3 activation, PI(4,5)P2 and TIRAP recruitment assays, and pathway blots\",\n      \"pmids\": [\"32415087\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Spatial site of ARF3 activation (Golgi vs plasma membrane) not resolved\", \"Whether ARF3 selectivity over ARF1 is intrinsic to BIG1 untested\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Identified 14-3-3ζ as a regulator that stabilizes BIG1 surface expression and its interaction with GABAA receptors to control chloride conductance.\",\n      \"evidence\": \"In vitro and in vivo co-IP, siRNA, overexpression, surface quantification, and Cl- influx assay in hippocampal neurons\",\n      \"pmids\": [\"36562883\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether 14-3-3ζ binding is phospho-dependent (e.g. via Ser-883) not tested\", \"Mechanism of surface stabilization unresolved\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Placed BIG1 downstream of KLF4 transcriptional control and within a PI3K/Akt/NF-κB axis driving microglial neuroinflammation.\",\n      \"evidence\": \"ChIP-qPCR, dual-luciferase reporter, siRNA, PI3K-agonist rescue, and migration/cytokine assays\",\n      \"pmids\": [\"35090882\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether BIG1 GEF activity mediates the inflammatory phenotype not tested\", \"Direct molecular link to NF-κB not established\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How BIG1's distinct functional modes — Golgi GEF catalysis, GEF-independent scaffolding of myosin phosphatase, and nuclear/nucleolar association — are coordinated within a single protein, and what governs ARF-isoform selectivity across these contexts, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural model integrating the catalytic, scaffolding, and nuclear functions\", \"Mechanism of context-specific ARF1 vs ARF3 selection unknown\", \"Direct nuclear molecular activity uncharacterized\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 12, 5]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 3, 5]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [15, 19]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [0, 11, 12, 14]},\n      {\"term_id\": \"GO:0005730\", \"supporting_discovery_ids\": [2, 8]},\n      {\"term_id\": \"GO:0005635\", \"supporting_discovery_ids\": [2, 8]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [2, 4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [9, 13, 21]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [19, 23]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [18, 23, 25]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [20, 21]}\n    ],\n    \"complexes\": [\n      \"myosin phosphatase complex (myosin IIA / PP1δ / MYPT1)\",\n      \"BIG1 homodimer/BIG-GBF1 dimer (DCB-HUS)\",\n      \"PDE3A-containing AKAP complex\"\n    ],\n    \"partners\": [\n      \"ARF1\",\n      \"ARL1\",\n      \"MYO9B\",\n      \"MYH9\",\n      \"FKBP13\",\n      \"CTNNB1\",\n      \"TRAF2\",\n      \"YWHAZ\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}